Gyon Technologies Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,107	Closed	-$232K	–	112
2020 Q1	$232K	Buy	+5,107	New	+$232K	0.45%	77